Search results
1 sie 2021 · Economy class syndrome refers to the occurrence of thrombotic events during long-haul flights, mainly in economy class passengers. The clinical condition defined here is observed not only in those travelling in economy class, but also in those travelling by land according to the studies.
26 maj 2017 · The term ‘economy class syndrome’ refers to the occurrence of thrombotic events during long-haul flights that mainly occur in passengers in the economy class of the aircraft. This syndrome results from several factors related to the aircraft cabin (immobilization, hypobaric hypoxia and low humidity) and the passenger (body mass index ...
1 kwi 2009 · Aspirin and P2Y 12 receptor antagonists have synergistic effects in blocking the final common pathway leading to platelet aggregation represented by GP IIb/IIIa receptor, which may be directly inhibited by intravenous GP IIb/IIIa receptor antagonists.
16 sie 2022 · According to 2019 guidelines on diabetes and cardiovascular diseases endorsed by the European Society of Cardiology (ESC) in collaboration with the European Association for the Study of Diabetes (EASD), it is possible to prescribe low-dose aspirin (75–100 mg daily) to patients at high and very high cardiovascular risk, unless contraindicated ...
6 sty 2023 · For low-molecular-weight heparin or oral anticoagulants, the existing literature 5 is not sufficient to support their use to prevent economy class syndrome. More research is needed to develop safe prophylactic interventions to lower risk of DVT on long-haul flights.
The term 'economy class syndrome' refers to the occurrence of thrombotic events during long-haul flights that mainly occur in passengers in the economy class of the aircraft. This syndrome results from several factors related to the aircraft cabin (immobilization, hypobaric hypoxia and low humidity) ….
The criteria for defining risk groups remains unclear and we outline our recommendations. There is conflicting evidence with regard to the use of aspirin but considering the latest evidence we do not recommend it.
